A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease.

Doueiry C, Kappler CS, Martinez-Morant C, Duncan SA
Int J Mol Sci. 2024 Jul 2;25(13):7277. doi: 10.3390/ijms25137277. PubMed Article

Plasmids from Article

ID	Plasmid	Purpose
255037	pMA-RQ-PNPLA3-I148M	Used to confer expression of PNPLA3 with the isoleucine 148 residue replaced with a methionine